Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer.
about
Iron Homeostasis in Health and DiseaseEvidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical PopulationsSerum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancerLung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data.Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunitiesUrinary protein biomarkers in the early detection of lung cancer.Subchronic pulmonary pathology, iron overload, and transcriptional activity after Libby amphibole exposure in rat models of cardiovascular disease.Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapySerum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes.Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry.Regulation of cellular iron metabolism and its implications in lung cancer progression.O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.Serum ferritin and primary lung cancer.Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro.Protein nanocages that penetrate airway mucus and tumor tissue.Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study
P2860
Q26775146-F6601D2B-FE62-496D-A0DE-E2E787C8F0C6Q28383815-70E54543-1C59-469A-A15C-2D34CE0A0274Q33566716-A63B97F9-BFB1-4B3C-A413-1FB5AC5645DDQ34466055-3A816296-B6E7-47DB-80B4-9EDC84080D54Q35034547-F59191F6-7E10-44DA-AAF9-B3A93CCA9578Q35044516-6E8A00D8-34BA-4BB3-B63A-884897B328BCQ35682798-8D9E7269-CFAB-4268-94DB-3B827DA72155Q36449810-58C47E66-0EC5-43DA-AAD1-F76443D0ACEEQ37012061-1DE9EC3D-381E-494F-82BF-975772074D4CQ37075985-FFEC756E-44C9-4124-AA45-AC6106AFE8A1Q37304950-A20A951C-96C7-439E-86B1-CB1256834CC4Q38214914-80C0B4B1-3938-4D3D-B879-3011112205F9Q38709364-0614C7CA-F697-4437-BB27-3A4E294A35BCQ47094158-5BD9A975-9503-4013-884F-81B5DCCF081EQ47109274-D2AB67BF-BABF-4FE7-82F2-9A7190E3391DQ47234596-695B3F3A-C3A1-478C-8E04-9516AD1166CEQ47885456-ED47A1B2-1A1F-4D26-8408-6AF4A70852DDQ57825151-5D1A11EF-9600-4A8F-A04A-BEFB92375BCF
P2860
Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@en
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@nl
type
label
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@en
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@nl
prefLabel
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@en
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Altered iron metabolism, infla ...... in non-small-cell lung cancer.
@en
P2093
Marija Poljak-Blazi
Milivoj Boranic
Simun Krizanac
Suzana Kukulj
Zarko Santic
P2860
P2888
P304
P356
10.1007/S12032-009-9203-2
P577
2009-03-24T00:00:00Z